Anti-complement immunofluorescence test for antibodies to human cytomegalovirus

Area of Science:

• Virology
• Immunology
• Medical Diagnostics

Background:

• Human cytomegalovirus (CMV) is a significant pathogen.
• Accurate serodiagnosis of CMV infections is crucial for patient management.
• Existing serological tests have limitations in sensitivity, specificity, or turnaround time.

Purpose of the Study:

• To develop and validate an anti-complement immunofluorescence (ACIF) test for detecting CMV antibodies.
• To optimize the ACIF test for speed, sensitivity, specificity, and reproducibility.
• To compare the ACIF test performance against established CMV serological assays.

Main Methods:

• Utilized an ACIF test detecting CMV antigen in infected cell nuclei.
• Investigated factors affecting ACIF test sensitivity and specificity.
• Compared ACIF results with complement fixation, indirect hemagglutination, and neutralization tests.
• Assessed ACIF for detecting antibody titer rises and stationary levels.

Main Results:

• The ACIF test demonstrated suitability for detecting significant CMV antibody titer changes.
• ACIF showed no heterotypic antibody responses from other human herpesvirus infections.
• Eliminated nonspecific cytoplasmic staining observed in indirect immunofluorescence.
• Successfully tested sera that were anti-complementary in complement fixation tests.

Conclusions:

• The ACIF test is a valuable and reproducible method for CMV antibody detection.
• ACIF offers advantages over other methods, including reduced nonspecific staining and suitability for anti-complementary sera.
• The ACIF test serves as an effective supplemental or backup procedure for CMV serodiagnosis.